Oregon Psilocybin Services: What’s Available, How It Works, and What It Costs
Oregon psilocybin services are legally available to any adult 21 or older, including visitors from out of state. No prescription or residency is required. Sessions take...
Psilocybin PTSD Therapy: What the 2026 Clinical Evidence Shows
Psilocybin PTSD therapy is no longer a fringe concept. A growing body of clinical research, including Phase 2 trials published in 2025, shows that a single...
Psychedelic Therapy California 2026: What’s Legal and What’s Not
Last Updated: May 2026 Psychedelic therapy in California is a complicated picture in 2026. Ketamine is the one legally accessible option through licensed medical providers, while...
MDMA Therapy FDA Decision, What the Rejection Letter Means for Seekers
The FDA rejected Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD, citing three specific concerns: gaps in safety reporting, insufficient evidence that benefits lasted over time,...
RFK Jr. and Psychedelic Therapy: What Seekers Should Know
RFK Jr. psychedelic therapy support has brought real political attention to substances like psilocybin, MDMA, and ibogaine. For seekers already exploring this space, the shift matters....
Psychedelic Therapy for Veterans: What the Research Shows
Psychedelic therapy for veterans is one of the most actively researched areas in mental health today. Clinical trials involving MDMA and psilocybin have shown meaningful reductions...
Ibogaine Treatment Texas: Veterans, $50M, and What Comes Next
Texas has committed $50 million to fund clinical trials for ibogaine treatment Texas programs focused on veterans and first responders. The research is early and the...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.